NAGK and Parkinson disease: In summary, we report NAGK acted in a non-canonical manner to reduce protein aggregates in neuronal and non-neuronal cellular models of HD and PD, and that these suppressions of protein aggregates also prevented mitochondrial damage and reduced ROS production.